Suchergebnisse - "Kainz, Alexander"

PubPharm (137)

1

Natural killer cell functional genetics and donor-specific antibody-triggered microvascular inflammation

enthalten in: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons | 2023

von Diebold, M. | Vietzen, H. | Heinzel, A. | +14

2

Early progression of chronic histologic lesions in kidney transplant biopsies is not associated with HLA histocompatibility

enthalten in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2023

von Jabbour, R. | Heinzel, A. | Reindl-Schwaighofer, R. | +9

3

Monitoring of Sotrovimab-Levels as Pre-Exposure Prophylaxis in Kidney Transplant Recipients Not Responding to SARS-CoV-2 Vaccines

enthalten in: Viruses | 2023

von Aschauer, C. | Heinzel, A. | Stiasny, K. | +9

4

Effect of Hydrogen Sulfide on Essential Functions of Polymorphonuclear Leukocytes

enthalten in: Toxins | 2023

von Farahat, S. | Kherkheulidze, S. | Nopp, S. | +4

5

Morphologic and Molecular Features of Antibody-Mediated Transplant Rejection : Pivotal Role of Molecular Injury as an Independent Predictor of Renal Allograft Functional Decline

enthalten in: Transplant international : official journal of the European Society for Organ Transplantation | 2023

von Herz, C. | Diebold, M. | Kainz, A. | +5

6

Lessons from effect of etelcalcetide on left ventricular hypertrophy in patients with end-stage kidney disease

enthalten in: Current opinion in nephrology and hypertension | 2022

von Dörr, K. | Kainz, A. | Oberbauer, R.

7

Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection : study protocol for a phase 2 trial

enthalten in: Trials | 2022

von Mayer, K. | Budde, K. | Halloran, P. | +16

8

Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial

enthalten in: Trials | 2022

von Mayer, K. | Budde, K. | Halloran, P. | +16

9

Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial

enthalten in: Trials | 2022

von Mayer, K. | Budde, K. | Halloran, P. | +16

10

Waiting Time for Second Kidney Transplantation and Mortality

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2022

von Kainz, A. | Kammer, M. | Reindl-Schwaighofer, R. | +7

CommentIn: Clin J Am Soc Nephrol. 2022 Jan;17(1):6-7. - PMID 34965956

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]